Skip to main content

Clonazepam

ADVERTISEMENT
Identification
Molecular formula
C15H10ClFN2O
CAS number
1622-61-3
IUPAC name
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
State
State

Clonazepam is typically found as a solid at room temperature, particularly in the form of tablets for oral administration.

Melting point (Celsius)
239.00
Melting point (Kelvin)
512.15
Boiling point (Celsius)
363.00
Boiling point (Kelvin)
636.15
General information
Molecular weight
315.72g/mol
Molar mass
315.7150g/mol
Density
1.8900g/cm3
Appearence

Clonazepam appears as a white to light yellow crystalline powder. It is odorless and has a distinct appearance commonly found in the pharmaceutical formulation of tablets.

Comment on solubility

Solubility of 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one

The solubility of 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (C15H10ClFN2O) can be influenced by various factors including its molecular structure and polarities. Here are some key aspects to consider:

  • Polar Nature: The presence of a chloro group (Cl) and a fluorophenyl moiety contributes to the molecule's polar characteristics, affecting its interaction with solvents.
  • Hydrogen Bonding: The nitrogen and oxygen in the molecule can participate in hydrogen bonding, which can enhance solubility in polar solvents like water.
  • Organic Solvents: This compound may be more soluble in organic solvents such as ethanol or dimethyl sulfoxide (DMSO), considering its organic nature.
  • pH Influence: The solubility of the compound may vary with pH, especially if protonation or deprotonation of specific functional groups occurs.

In summary, while this compound may possess some degree of solubility in polar solvents due to its functional groups, the exact solubility can fluctuate based on the solvent used, temperature, and the pH of the solution. Experiments are advisable for precise solubility determinations.

Interesting facts

Interesting Facts about 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one

The compound 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one is a notable member of the benzodiazepine family, which is well recognized for its pharmacological properties. Here are some captivating aspects of this compound:

  • Pharmacological Relevance: Benzodiazepines are widely used in medicine for their anxiolytic (anxiety-reducing), sedative, and muscle relaxant properties. This compound, like others in its class, may show potential as a therapeutic agent.
  • Structural Insight: The presence of the chlorine atom at the 7-position and the fluorophenyl group significantly contributes to the unique chemical behavior and biological activity of this compound.
  • Research Potential: Compounds with modifications, such as the fluoro group, are often studied for their enhanced potency and specificity. The interplay between structural modifications and biological effects renders this compound a valuable subject for pharmaceutical research.
  • Mechanism of Action: Benzodiazepines are known to work by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, leading to increased neuronal inhibition, which is essential for their calming effects.
  • Ingredient of Interest: This compound is part of ongoing research, aiming to develop new medications that are more effective and exhibit fewer side effects compared to traditional benzodiazepines.

In summary, the exploration of 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one not only enhances our understanding of benzodiazepine chemistry but also holds the promise for future therapeutic advancements. The chemistry behind it exemplifies how tiny changes in structure can lead to significant differences in activity.

Synonyms
2886-65-9
Norfludiazepam
Norflutoprazepam
norflurazepam
Descarbethoxyloflazepate
7-Chloro-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-
Ro 5-3367
CM 7116
7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Sch 17514
nor-Flurazepam
7-Chloro-5-(2-fluoro-phenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
CHEMBL974
Norfludiazepam; Norflurazepam
X9U41NXR6M
MLS000028851
2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-
2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-7-CHLORO-5-(2-FLUOROPHENYL)-
SMR000058397
(E)-7-Chloro-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one
nor-Flurazepam (1.0 mg/mL in Methanol)
EINECS 220-748-3
UNII-X9U41NXR6M
BRN 0754061
CM-7116
Opera_ID_747
5-24-04-00319 (Beilstein Handbook Reference)
MLS001146946
SCHEMBL5177297
DTXSID30183057
CHEBI:135197
HMS2236J07
HMS3371H16
Norfludiazepam, analytical standard
LBC43001
BDBM50408014
MFCD00083443
SCH-17514
AKOS015854231
Desalkylflurazepam, 1mg/ml in Methanol
FC26451
Ro-053367
NCGC00247051-01
NCGC00247051-02
Ro-05-3367
AC-11173
DS-18402
J13.722G
MIDAZOLAM IMPURITY F [EP IMPURITY]
DB-047480
NS00010456
F21326
Q27293739
FLURAZEPAM MONOHYDROCHLORIDE IMPURITY B [EP IMPURITY]
7-Chloro-5-(2-fluorophenyl)-1H-benzo-[e][1,4]diazepin-2(3H)-one
7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
7-chloro-1,3-dihydro-5 -(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one
7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one
7-chloro-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepine-2-one
7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one
5-(2-Fluorophenyl)-1,3-dihydro-7-chloro-2H-1,4-benzodiazepin-2-one;Norfludiazepam;Desalkylflurazepam